Is there more than meets the eye than sentinel node localisation during lymphoscintigraphy mapping? Potential immunologic and therapeutic implications
暂无分享,去创建一个
F. Giammarile | G. Treglia | R. D. Delgado Bolton | A. K. Calapaquí Terán | Adriana K. Calapaquí Terán | Roberto C. Delgado Bolton
[1] F. Hölzle,et al. Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head , 2022, European Journal of Nuclear Medicine and Molecular Imaging.
[2] S. Fanti,et al. The Concept of Strength Through Synergy Applied to the Search of Powerful Prognostic Biomarkers in Gastroesophageal Cancer: An Example Based on Combining Clinicopathological Parameters, Imaging-Derived Sarcopenia Measurements, and Radiomic Features. , 2022, Clinical nuclear medicine.
[3] S. Fanti,et al. New Biomarkers With Prognostic Impact Based on Multitracer PET/CT Imaging in Neuroendocrine Neoplasms: The Light Leading Out of the Darkness in Challenging Tumors. , 2022, Clinical nuclear medicine.
[4] F. Giammarile,et al. The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions. , 2021, Clinical nuclear medicine.
[5] P. Erba,et al. Medical imaging in times of pandemic: focus on the cornerstones of successful imaging , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[6] F. Giammarile,et al. Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer. , 2021, Seminars in nuclear medicine.
[7] M. Aapro,et al. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer. , 2020, Lung cancer.
[8] C. Kuhl,et al. The requirements of a specialist breast centre , 2020, Breast.
[9] Alberto Costa,et al. ECCO Essential Requirements for Quality Cancer Care: Prostate cancer. , 2020, Critical reviews in oncology/hematology.
[10] W. Oyen,et al. The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Alberto Costa,et al. ECCO essential requirements for quality cancer care: Melanoma. , 2018, Critical reviews in oncology/hematology.
[12] Murugesan V. S. Rajaram,et al. γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206) , 2015, The Journal of Immunology.
[13] G. Liszkay,et al. Immune cell profile of sentinel lymph nodes in patients with malignant melanoma – FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome , 2013, Journal of Translational Medicine.
[14] Katsumasa Takahashi,et al. Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer. , 2005, Oral oncology.
[15] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.